MyHep All Tablet Description:
- MyHep All is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults.
- It is used in patients with HCV genotype 1, 2, 3, 4, 5, or 6, including those with compensated cirrhosis (Child-Pugh A).
- MyHep All is used as a part of a combination regimen with or without ribavirin, depending on the specific genotype and patient population.
Dosage of MyHep All Tablet:
- The recommended dosage of MyHep All is one tablet taken orally once daily, with or without food.
- The duration of treatment may vary depending on the HCV genotype and patient population, and should be determined by a qualified healthcare provider.
- It is important to take MyHep All exactly as prescribed by your healthcare provider.
- MyHep All should be stored at room temperature between 20°C to 25°C (68°F to 77°F).
- Keep it in a dry place, away from moisture and heat.
- Keep it out of reach of children and pets.
Side Effects of MyHep All Tablet:
Common side effects of MyHep All may include:
- Muscle or joint pain
- Decreased appetite
If you experience any severe or persistent side effects, contact your healthcare provider immediately.
- MyHep All should only be used under the supervision of a qualified healthcare provider who is experienced in the treatment of chronic hepatitis C.
- Inform your healthcare provider of any other medications, supplements, or herbal products you are taking, as MyHep All may interact with other medications.
- MyHep All is not recommended for use in pregnant or breastfeeding individuals, as its safety during pregnancy and lactation has not been established.
- MyHep All may interact with certain medications, including those that are metabolized by the liver. Inform your healthcare provider of all medications you are taking to avoid potential interactions.
- MyHep All may cause a decrease in kidney function, especially in patients with pre-existing kidney disease. Regular monitoring of kidney function is recommended during treatment.
- MyHep All may cause a flare-up of hepatitis B virus (HBV) in patients who are co-infected with HBV and HCV. Monitoring for HBV reactivation is recommended in patients at risk.
- MyHep All may interact with certain herbal supplements or alternative therapies. Consult your healthcare provider before using any herbal products during treatment with MyHep All.
- MyHep All may interact with other medications, including those that are metabolized by the liver or affect the kidney function. Inform your healthcare provider of all medications you are taking, including over-the-counter medications and supplements, to avoid potential interactions.
How should I take MyHep All?
MyHep All should be taken orally once daily, with or without food, as prescribed by your healthcare provider. Follow the recommended dosage and duration of treatment.
Can I drink alcohol while taking MyHep All?
It is recommended to avoid alcohol consumption during treatment with MyHep All, as it may increase the risk of liver toxicity and adverse effects.
How long is the treatment duration with MyHep All?
The treatment duration with MyHep All may vary depending on the HCV genotype and patient population. It is determined by a qualified healthcare provider based on individual patient
- MyHep All is a prescription medication and should only be used under the guidance of a qualified healthcare provider.
- It is important to complete the full course of treatment as prescribed, even if you start feeling better before the treatment is finished.
- Regular monitoring of liver function, kidney function, and HCV viral load may be required during treatment with MyHep All to ensure the effectiveness and safety of the medication.
- MyHep All is not recommended for use in pediatric patients below 18 years of age, as its safety and effectiveness in this population have not been established.
- MyHep All does not prevent the spread of HCV to others, and appropriate precautions should be taken to prevent transmission of the virus, such as avoiding sharing needles or engaging in unprotected sex.
MyHep All Prescribing Information. https://www.mylan.in/
Recommendations for Testing, Managing, and Treating Hepatitis C. https://www.hcvguidelines.org/